NOTE: If you are having login problems due to recent site updates, please try either clearing your browser cache, quitting and restarting your browser, or restarting/rebooting your computer/device and try again. Please email tech support if you have continued problems.


GRACE :: Kidney Cancer

Immunotherapy Treatments for Kidney Cancer

Dr. Guru Sonpavde highlights the top research news in immunotherapy for kidney cancer from the ASCO 2014 Annual Meeting.


Evaluating Biomarkers in Kidney Cancer

Biomarkers can give clues to many predictive and prognostic issues, like how a patient may respond to a drug or if a patient’s cancer is likely to recur. Dr. Daniel Heng discusses what researchers are learning.


Will Combining Immunotherapies Better Fight Kidney Cancer?

Dr. Lauren Harshman discusses what combinations of drugs are being studied in kidney cancer patients.


Cabozantinib for Late Stage Kidney Cancer

Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer.


The Best Thing You Can Do As a Kidney Cancer Patient

Dr. Daniel Heng has advice to kidney cancer patients who want the best treatment for their disease. To find a clinical trial that is right for you, visit clinicaltrials.gov and enter “kidney cancer” in the search box.


Ask Us, Q&A
Kidney Cancer Expert Content

Archives

Archives

Lung Cancer Awareness Month Information

 


GRACE Website Rebuild

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

ClinicalTrials.gov


Biomedical Learning Institute

PeerView Press - Curriculum-Based Learning Activities